Du Y - Search Results

1

Salidroside inhibits the growth of human breast cancer in vitro and in vivo.

Zhao G, Shi A, Fan Z, Du Y. Zhao G, et al. Among authors: du y. Oncol Rep. 2015 May;33(5):2553-60. doi: 10.3892/or.2015.3857. Epub 2015 Mar 17. Oncol Rep. 2015. PMID: 25814002

2

[The treatment of enterogenous cyst: a report of 12 cases].

Du YD, Cao LN, Zhao G. Du YD, et al. Zhonghua Wai Ke Za Zhi. 1994 Jan;32(1):49-50. Zhonghua Wai Ke Za Zhi. 1994. PMID: 8045205 Chinese.

3

COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.

Du Y, Shi A, Han B, Li S, Wu D, Jia H, Zheng C, Ren L, Fan Z. Du Y, et al. Int J Oncol. 2014 Apr;44(4):1385-93. doi: 10.3892/ijo.2014.2299. Epub 2014 Feb 12. Int J Oncol. 2014. PMID: 24535190

4

Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.

Zhang W, Du Y, Jiang T, Geng W, Yuan J, Zhang D. Zhang W, et al. Among authors: du y. Mol Med Rep. 2015 Aug;12(2):2919-25. doi: 10.3892/mmr.2015.3757. Epub 2015 May 7. Mol Med Rep. 2015. Retraction in: Mol Med Rep. 2021 Aug;24(2):586. doi: 10.3892/mmr.2021.12225 PMID: 25955394 Retracted.

5

Additive effects of eukaryotic co‑expression plasmid carrying GRIM‑19 and LKB1 genes on breast cancer in vitro and in vivo.

Zhang W, Shao Y, Du Y, Geng W, Jiang T, Liu H, Zhang D. Zhang W, et al. Among authors: du y. Mol Med Rep. 2015 Nov;12(5):7665-72. doi: 10.3892/mmr.2015.4393. Epub 2015 Sep 30. Mol Med Rep. 2015. Retraction in: Mol Med Rep. 2021 Aug;24(2):587. doi: 10.3892/mmr.2021.12226 PMID: 26458553 Retracted.

6

Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.

Han B, Du Y, Fu T, Fan Z, Xu S, Hu C, Bi L, Gao T, Zhang H, Xu W. Han B, et al. Among authors: du y. Appl Spectrosc. 2017 Feb;71(2):300-307. doi: 10.1177/0003702816681009. Epub 2016 Dec 20. Appl Spectrosc. 2017. PMID: 28181469

7

Prognostic value of routine laboratory variables in prediction of breast cancer recurrence.

Zhu Z, Li L, Ye Z, Fu T, Du Y, Shi A, Wu D, Li K, Zhu Y, Wang C, Fan Z. Zhu Z, et al. Among authors: du y. Sci Rep. 2017 Aug 15;7(1):8135. doi: 10.1038/s41598-017-08240-2. Sci Rep. 2017. PMID: 28811593 Free PMC article.

8

Suppressive role of miR-592 in breast cancer by repressing TGF-β2.

Hou W, Zhang H, Bai X, Liu X, Yu Y, Song L, Du Y. Hou W, et al. Among authors: du y. Oncol Rep. 2017 Dec;38(6):3447-3454. doi: 10.3892/or.2017.6029. Epub 2017 Oct 12. Oncol Rep. 2017. PMID: 29039599

9

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement.

Gao P, You L, Wu D, Shi A, Miao Q, Rana U, Martin DP, Du Y, Zhao G, Han B, Zheng C, Fan Z. Gao P, et al. Among authors: du y. Patient Prefer Adherence. 2018 May 22;12:887-897. doi: 10.2147/PPA.S167004. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 29872274 Free PMC article.

10

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Gao P, Wang X, Jin Y, Hu W, Duan Y, Shi A, Du Y, Song D, Yang M, Li S, Han B, Zhao G, Zhang H, Fan Z, Miao QR. Gao P, et al. Among authors: du y. Breast Cancer Res. 2018 Sep 12;20(1):112. doi: 10.1186/s13058-018-1028-5. Breast Cancer Res. 2018. PMID: 30208932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,645 results

Search Page

Filters